OPTIMIZING SIZE SELECTIVITY AND CATCH PATTERNS FOR HAKE (MERLUCCIUS MERLUCCIUS) AND BLUE WHITING (MICROMESISTIUS POUTASSOU) BY COMBINING SQUARE MESH PANEL AND CODEND DESIGNS.

Optimizing size selectivity and catch patterns for hake (Merluccius merluccius) and blue whiting (Micromesistius poutassou) by combining square mesh panel and codend designs.

Gear modifications in fisheries are usually implemented to obtain catch patterns that meet management objectives.In the Basque bottom trawl fishery, gear regulations include the use of a square mesh panel (SMP) placed at the top panel of the extension piece of the trawl to supplement diamond mesh codend selectivity.However, Soccer - Protective - Sh

read more

Transport of sediments, carbon and nutrients in areas of reforestation and grassland based on simulated rainfall

The objective of this study was to evaluate the soil losses, as well as carbon and chemical samples in runoff through areas of pine (Pinus taeda), eucalyptus (Eucalyptus dunni) and a consortium of pasture with oat (Avena stringosa) and ryegrass (Lolium multiflorium) in the Fragosos river basin, in Concordia, SC.For this, rainfall simulations with S

read more

Model assessment of individual tumor control rate and adverse effects in comparing locally advanced cervical cancer treatment using intracavitary with and without interstitial brachytherapy

Purpose : This study assessed the modeled probability of tumor control and organ at risk toxicities in locally advanced cervical cancer in patients treated by external beam radiation plus brachytherapy using intracavitary combined with interstitial brachytherapy (IC/IS) vs.intracavitary brachytherapy (IC) alone.Material and methods: Twenty cervical

read more


Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care

Background: Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists is well established for the treatment of men with metastatic prostate cancer.As clear differences in efficacy, safety, or tolerability between the available LHRH agonists are lacking, the healthcare management team needs to look to soccer packs

read more